Articles

Drug design is growing up. Sophisticated, standardised, smart methods of developing new chemical entities (NCEs) are now the order of the day. No Topic shows this better than drug transporter proteins. Read about the latest research on this hot topic. Read more

The survey carried out the research team here at Pharma IQ in April has revealed many of the most important trends within Clinical Trial Supply and it suggests many reasons to be optimistic. Read our ten top stats! Read more

Angelina Jolie published an op-ed in the New York Times about her decision to undergo a preventative double mastectomy in response to learning that she carried a defective version of the BRCA1 gene has banished all doubt that we are living in a post-genomic world. Our editor explores the issues raised in this story Read more

In January this year the Chinese State Food and Drug Administration (SFDA) published a newly revised Good Supply Practice for Pharmaceutical Products (GSP), which will go into effect as of June 1, 2013. The revised guidance sets higher qualification requirements, increases standards for drug distribution and also has higher requirements for quality management. Read more

Brazil’s National Health Surveillance Agency (Anvisa) opened a consultation on the 4th April to propose the formation of an electronic tracking system for drugs from point of production through to the point of dispensing to the patient. Read more

In a move which has baffled some and angered others, Canada Health has approved influenzinium, a nosode as a vaccine for flu. At a time that many consider critical for public health and vaccination programs, this move has caused outrage in the scientific community. Our editor inspects the issues surrounding this controversial topic. Read more

The old argument of nature vs nurture has been known to be a false dilemma for a long time, the true making of an organism lies in both and no topic illustrates this better than epigenetics. What is epigenetics and why is it important? In this introduction we explore the history and principles of this blossoming field. Read more

In a fiscally constrained environment it is unsurprising that one of the lightening rods has been drug pricing. In this article, we explore 4 of the biggest battles that have erupted on this contentious topic in recent years. Let us know where you think these battles are headed and what can be done to resolve them. Read more

Cold chain annual expenditure is expected to increase to address cold chain equipment gaps in immunisation programs. Read more

The clinical trials transparency movement has received global attention, generated miles of column inches and at least one best selling book. Our editor takes a look at the phenomenon and the latest developments in this ever-evolving story. We ask, how does this story affect you and your business? Read more